NARI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NARI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-12-14), Inari Medical's share price is $55.59. Inari Medical's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $1.33. Hence, Inari Medical's Price to Tangible Book Ratio of today is 41.86.
The historical rank and industry rank for Inari Medical's Price-to-Tangible-Book or its related term are showing as below:
During the past 6 years, Inari Medical's highest Price to Tangible Book Ratio was 42.43. The lowest was 7.64. And the median was 17.45.
A closely related ratio is called PB Ratio. As of today, Inari Medical's share price is $55.59. Inari Medical's Book Value per Sharefor the quarter that ended in Sep. 2024 was $7.44. Hence, Inari Medical's P/B Ratio of today is 7.47.
The historical data trend for Inari Medical's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inari Medical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | - | 21.47 | 19.20 | 8.23 | 37.61 |
Inari Medical Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | 8.32 | 37.61 | 30.31 | 36.70 | 31.05 |
For the Medical Devices subindustry, Inari Medical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Inari Medical's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Inari Medical's Price-to-Tangible-Book falls into.
Inari Medical's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Sep. 2024 ) |
= | 55.59 | / | 1.328 | |
= | 41.86 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Inari Medical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew Hykes | officer: Chief Operating Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
William Hoffman | director, officer: President and CEO | C/O INARI MEDICAL, INC., 9 PARKER, SUITE 100, IRVINE CA 92618 |
Mitch C. Hill, | officer: Chief Financial Officer | 1009 TENNYSON DRIVE, SOUTHLAKE TX 76902 |
Thomas Tu | officer: Chief Medical Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
Rebecca Chambers | director | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Donald B Milder | director | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
Robert Keith Warner | director | C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Cynthia L Lucchese | director | 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260 |
Mead Dana G Jr. | director | 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Jonathan D Root | director | 2735 SAND HILL ROAD, MENLO PARK CA 94025 |
Cooperatieve Gilde Healthcare Iv U.a. | 10 percent owner | NEWTONLANN 51, UTRECHT P7 3508AB |
Kirk G. Nielsen | director, 10 percent owner | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Gilde Healthcare Iv Management B.v. | 10 percent owner | NEWTONLAAN 91, UTRECHT P7 3584 BP |
Gilde Healthcare Holding B.v. | 10 percent owner | NEWTONLAAN 91, PO BOX 85067, 3508 UTRECHT P7 AB |
From GuruFocus
By Marketwired • 10-07-2024
By GuruFocus Research • 09-18-2024
By GuruFocus News • 11-01-2024
By PRNewswire • 10-21-2024
By GuruFocus News • 10-14-2024
By GuruFocus Research • 08-20-2024
By GuruFocus News • 10-29-2024
By GuruFocus News • 10-02-2024
By GuruFocus News • 10-29-2024
By Marketwired • 12-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.